The reiteration of an Outperform rating by Wedbush analyst Robert Driscoll indicates a positive outlook for Replimune Group's stock. The maintained $52 price target suggests that the analyst believes the stock has potential for growth in the short term. This news is likely to have a positive impact on the stock price.